Table 3 Recovery of EK and Native peptide in triple-Q MS using SRM.

From: Identification, characterization and control of a sequence variant in monoclonal antibody drug product: a case study

Amount (p moles)

Peak area

Calculated amount from linear plot (pmoles)

%Recovery (actual/calculated)

EK peptide

0.065

68,305

0.062

1.0

0.130

186,779

0.146

0.9

0.325

390,302

0.292

1.1

0.651

947,436

0.690

0.9

3.255

4,829,049

3.462

0.9

6.510

9,465,545

6.773

1.0

32.550

43,326,864

30.954

1.1

65.100

83,221,433

59.444

1.1

Native peptide

126.187

86,146,234

118.632

1.1

252.375

182,163,787

277.256

0.9

378.562

257,317,432

401.412

0.9

504.749

327,136,398

516.756

1.0

630.936

407,050,857

648.777

1.0

757.124

459,068,585

734.712

1.0

883.311

518,580,860

833.029

1.1

1009.498

585,917,249

944.271

1.1